200 related articles for article (PubMed ID: 30702441)
1. Ascorbic acid-induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma.
Shenoy N; Bhagat TD; Cheville J; Lohse C; Bhattacharyya S; Tischer A; Machha V; Gordon-Mitchell S; Choudhary G; Wong LF; Gross L; Ressigue E; Leibovich B; Boorjian SA; Steidl U; Wu X; Pradhan K; Gartrell B; Agarwal B; Pagliaro L; Suzuki M; Greally JM; Rakheja D; Thompson RH; Susztak K; Witzig T; Zou Y; Verma A
J Clin Invest; 2019 Mar; 129(4):1612-1625. PubMed ID: 30702441
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic dysregulation by aberrant metabolism in renal cell carcinoma can be reversed with Ascorbic acid.
Shenoy N
Mol Cell Oncol; 2019; 6(3):1595309. PubMed ID: 31131312
[TBL] [Abstract][Full Text] [Related]
3. Functional succinate dehydrogenase deficiency is a common adverse feature of clear cell renal cancer.
Aggarwal RK; Luchtel RA; Machha V; Tischer A; Zou Y; Pradhan K; Ashai N; Ramachandra N; Albanese JM; Yang JI; Wang X; Aluri S; Gordon S; Aboumohamed A; Gartrell BA; Hafizi S; Pullman J; Shenoy N
Proc Natl Acad Sci U S A; 2021 Sep; 118(39):. PubMed ID: 34551979
[TBL] [Abstract][Full Text] [Related]
4. Restoration of 5-hydroxymethylcytosine by ascorbate blocks kidney tumour growth.
Ge G; Peng D; Xu Z; Guan B; Xin Z; He Q; Zhou Y; Li X; Zhou L; Ci W
EMBO Rep; 2018 Aug; 19(8):. PubMed ID: 29959161
[TBL] [Abstract][Full Text] [Related]
5. Vitamin C increases 5-hydroxymethylcytosine level and inhibits the growth of bladder cancer.
Peng D; Ge G; Gong Y; Zhan Y; He S; Guan B; Li Y; Xu Z; Hao H; He Z; Xiong G; Zhang C; Shi Y; Zhou Y; Ci W; Li X; Zhou L
Clin Epigenetics; 2018 Jul; 10(1):94. PubMed ID: 30005692
[TBL] [Abstract][Full Text] [Related]
6. Loss of 5-hydroxymethylcytosine is linked to gene body hypermethylation in kidney cancer.
Chen K; Zhang J; Guo Z; Ma Q; Xu Z; Zhou Y; Xu Z; Li Z; Liu Y; Ye X; Li X; Yuan B; Ke Y; He C; Zhou L; Liu J; Ci W
Cell Res; 2016 Jan; 26(1):103-18. PubMed ID: 26680004
[TBL] [Abstract][Full Text] [Related]
7. Global 5-Hydroxymethylcytosine Levels Are Profoundly Reduced in Multiple Genitourinary Malignancies.
Munari E; Chaux A; Vaghasia AM; Taheri D; Karram S; Bezerra SM; Gonzalez Roibon N; Nelson WG; Yegnasubramanian S; Netto GJ; Haffner MC
PLoS One; 2016; 11(1):e0146302. PubMed ID: 26785262
[TBL] [Abstract][Full Text] [Related]
8. HIF1α is not a target of 14q deletion in clear cell renal cancer.
Shenoy N
Sci Rep; 2020 Oct; 10(1):17642. PubMed ID: 33077781
[TBL] [Abstract][Full Text] [Related]
9. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis.
Carella A; Tejedor JR; García MG; Urdinguio RG; Bayón GF; Sierra M; López V; García-Toraño E; Santamarina-Ojeda P; Pérez RF; Bigot T; Mangas C; Corte-Torres MD; Sáenz-de-Santa-María I; Mollejo M; Meléndez B; Astudillo A; Chiara MD; Fernández AF; Fraga MF
Int J Cancer; 2020 Jan; 146(2):373-387. PubMed ID: 31211412
[TBL] [Abstract][Full Text] [Related]
11. Role of ten-eleven translocation proteins and 5-hydroxymethylcytosine in hepatocellular carcinoma.
Wang P; Yan Y; Yu W; Zhang H
Cell Prolif; 2019 Jul; 52(4):e12626. PubMed ID: 31033072
[TBL] [Abstract][Full Text] [Related]
12. L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer.
Shim EH; Livi CB; Rakheja D; Tan J; Benson D; Parekh V; Kho EY; Ghosh AP; Kirkman R; Velu S; Dutta S; Chenna B; Rea SL; Mishur RJ; Li Q; Johnson-Pais TL; Guo L; Bae S; Wei S; Block K; Sudarshan S
Cancer Discov; 2014 Nov; 4(11):1290-8. PubMed ID: 25182153
[TBL] [Abstract][Full Text] [Related]
13. 5-Hydroxymethylcytosine-mediated alteration of transposon activity associated with the exposure to adverse in utero environments in human.
Sun M; Song MM; Wei B; Gao Q; Li L; Yao B; Chen L; Lin L; Dai Q; Zhou X; Tao J; Chen J; He C; Jin P; Xu Z
Hum Mol Genet; 2016 Jun; 25(11):2208-2219. PubMed ID: 27005421
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer.
Storebjerg TM; Strand SH; Høyer S; Lynnerup AS; Borre M; Ørntoft TF; Sørensen KD
Clin Epigenetics; 2018 Aug; 10(1):105. PubMed ID: 30086793
[TBL] [Abstract][Full Text] [Related]
15. Diminished expression of 5hmc in Reed-Sternberg cells in classical Hodgkin lymphoma is a common epigenetic marker.
Siref A; McCormack C; Huang Q; Lim W; Alkan S
Leuk Res; 2020 Sep; 96():106408. PubMed ID: 32659407
[TBL] [Abstract][Full Text] [Related]
16. Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma.
Nagao K; Shinohara N; Smit F; de Weijert M; Jannink S; Owada Y; Mulders P; Oosterwijk E; Matsuyama H
BMC Cancer; 2018 Nov; 18(1):1114. PubMed ID: 30442117
[TBL] [Abstract][Full Text] [Related]
17. Altered 5-Hydroxymethylcytosine Landscape in Primary Gastric Adenocarcinoma.
Liu H; Xu T; Cheng Y; Jin MH; Chang MY; Shu Q; Allen EG; Jin P; Wang X
DNA Cell Biol; 2019 Dec; 38(12):1460-1469. PubMed ID: 31657619
[TBL] [Abstract][Full Text] [Related]
18. RNA-binding protein QKI-5 inhibits the proliferation of clear cell renal cell carcinoma via post-transcriptional stabilization of RASA1 mRNA.
Zhang RL; Yang JP; Peng LX; Zheng LS; Xie P; Wang MY; Cao Y; Zhang ZL; Zhou FJ; Qian CN; Bao YX
Cell Cycle; 2016 Nov; 15(22):3094-3104. PubMed ID: 27767378
[TBL] [Abstract][Full Text] [Related]
19. Epigenomic landscape of 5-hydroxymethylcytosine reveals its transcriptional regulation of lncRNAs in colorectal cancer.
Hu H; Shu M; He L; Yu X; Liu X; Lu Y; Chen Y; Miao X; Chen X
Br J Cancer; 2017 Feb; 116(5):658-668. PubMed ID: 28141796
[TBL] [Abstract][Full Text] [Related]
20. SENP1 promotes proliferation of clear cell renal cell carcinoma through activation of glycolysis.
Dong B; Gao Y; Kang X; Gao H; Zhang J; Guo H; You MJ; Xue W; Cheng J; Huang Y
Oncotarget; 2016 Dec; 7(49):80435-80449. PubMed ID: 27741516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
